Goldline Pharmaceutical Ltd (544759) — Board Meeting | 29 August 2026
Goldline Pharmaceutical held its 22nd AGM on August 29, 2026 in Nagpur, adopting FY2025-26 financials with revenue rising to ₹3,119.88 lakhs and profit to ₹411.71 lakhs, declaring a ₹12 dividend per preference share, and reappointing Director Karkare, while highlighting post-listing growth plans and governance commitments.
About Goldline Pharmaceutical Ltd (544759)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when 544759 files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track 544759 — Free💡 Ask AI about this filing
📊 More 544759 filings
- 🟡 Voting Results — 31 August 2026 Goldline Pharmaceutical held its AGM on 29 August 2026, appointing CS Avinash Gandhewar as scrutiniz...
🔥 Also filed on 29 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts for your stocks — summarized by AI daily
Set up your AI Radar — pick stocks, get daily email summaries of new filings.
Set up AI Radar — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd